A cohort study investigating aspirin use and survival in men with prostate cancer

Annals of Oncology

Volumn 25, Issue 1, 2014, Pages 154-159

  Flahavan, E M ^a   Bennett, K ^a   Sharp, L ^b   Barron, T I ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

Aspirin; Mortality; Pharmacoepidemiology; Prostate neoplasm

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DRUG SAFETY; DRUG USE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; VERY ELDERLY;

ASPIRIN; MORTALITY; PHARMACOEPIDEMIOLOGY; PROSTATE NEOPLASM;

AGED; ASPIRIN; COHORT STUDIES; COMBINED MODALITY THERAPY; CYCLOOXYGENASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RISK; TREATMENT OUTCOME;

EID: 84894700989     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt428     Document Type: Article

References (20)

1. Nash GF, Turner LF, Scully MF et al. Platelets and cancer. Lancet Oncol 2002; 3: 425-430.
2. Liu XH, Kirschenbaum A, Yao S et al. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 2000; 164: 820-825.
3. Rothwell PM, Fowkes FG, Belch JF et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31-41.
4. Jacobs EJ, Newton CC, Gapstur SM et al. Daily aspirin use and cancer mortality in a large US cohort. J Natl Cancer Inst 2012; 104: 1208-1217.
5. Rothwell PM, Wilson M, Price JF et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012; 379: 1591-1601.
6. Choe KS, Cowan JE, Chan JM et al. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol 2012; 30: 3540-3544.
7. Dhillon PK, Kenfield SA, Stampfer MJ et al. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort. Cancer Prev Res (Phila) 2012; 5: 1223-1228.
8. La Vecchia C, Bosetti C. Urological cancer: aspirin and the risk of prostate cancer mortality. Nat Rev Clin Oncol 2012; 9: 616-617.
9. Wacholder S. Design issues in case-control studies. Stat Methods Med Res 1995; 4: 293-309.
10. Fleming I, Cooper J, Henson D et al. American Joint Committee on Cancer: AJCC Cancer Staging Manual. Philadelphia, PA, USA: Lippincott-Raven 1997.
11. Fritz AG, Jack A, Percy C et al. International Classification of Diseases for Oncology: ICD-O. Geneva: World Health Organization 2000.
12. Schneeweiss S, Seeger JD, Maclure M et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854-864.
13. Onitilo AA, Engel JM, Glurich I et al. Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control 2012; 23: 967-981.
14. Buhmeida A, Pyrhonen S, Laato M et al. Prognostic factors in prostate cancer. Diagn Pathol 2006; 1: 4.
15. Kenfield SA, Stampfer MJ, Chan JM et al. Smoking and prostate cancer survival and recurrence. JAMA 2011; 305: 2548-2555.
16. Katz MS, Carroll PR, Cowan JE et al. Association of statin and nonsteroidal antiinflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int 2010; 106: 627-632.
17. Grytli HH, Fagerland MW, Fossa SD et al. Use of beta-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate 2013; 73: 250-260.
18. Fleshner NE, Lucia MS, Egerdie B et al. Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. Lancet 2012; 379: 1103-1111.
19. Daugherty SE, Pfeiffer RM, Ghazarian A et al. Frequency of aspirin use and prostate cancer mortality among prostate cancer cases in the control arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research. Edition. Washington, DC: AACR 2013.
20. Assayag J, Azoulay L, Yin H et al. Aspirin use in prostate cancer and the risk of death and metastasis. In: American Society of Clinical Oncology Annual Meeting 2013, Edition. Chicago: J Clin Oncol 2013; 31 (suppl; abstr 1518).